BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 5370166)

  • 1. [On the therapeutic effect of sordinol and fluanxol in the treatment of schizophrenic patients].
    Kontsevoi VA; Panteleeva GP; Zavidovskaia GI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(8):1238-43. PubMed ID: 5370166
    [No Abstract]   [Full Text] [Related]  

  • 2. [Action of flupentixol decanoate in chronic psychoses of the schizophrenic type].
    Evrard E; Heusghem C; Molders V; Plomteux G; Lebas A
    Acta Psychiatr Belg; 1972 Sep; 72(5):573-94. PubMed ID: 4669430
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of schizophrenic states with a new long-acting tranquilizer].
    Buisson JF
    Ann Med Psychol (Paris); 1973 Feb; 2(2):287-93. PubMed ID: 4749248
    [No Abstract]   [Full Text] [Related]  

  • 4. A controlled comparison of clopenthixol and perphenazine in a chronic schizophrenic population.
    Dehnel LL; Vestre ND; Schiele BC
    Curr Ther Res Clin Exp; 1968 Apr; 10(4):169-76. PubMed ID: 4967871
    [No Abstract]   [Full Text] [Related]  

  • 5. Clopenthixol in schizophrenia. Comparison of two groups of patients treated by the same drug.
    Vinar O; Bastecký J; Taussigová D; Formánková M; Růzicka S
    Act Nerv Super (Praha); 1967 Nov; 9(4):401-4. PubMed ID: 4889074
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical treatment of chronic psychoses with flupenthixol-decanoate (Fluanxol-Depot)].
    Gross H; Kaltenbäck E
    Wien Klin Wochenschr; 1972 Feb; 84(5):80-4. PubMed ID: 5015880
    [No Abstract]   [Full Text] [Related]  

  • 7. A clinical evaluation of clopenthixol.
    Yaryura-Tobias JA; Wolpert A; White L; Agola P; Merlis S
    Curr Ther Res Clin Exp; 1970 May; 12(5):271-9. PubMed ID: 4986242
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experiences with Fluanxol-depot ampules in the treatment of patients with chronic psychoses].
    Schwalbe W
    Z Allgemeinmed; 1971 Dec; 47(36):1919-22. PubMed ID: 5142254
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical and EEG study (polygraph recording) of a new neuroleptic drug: Sordinol (clopenthixol)].
    Urbani M; Costa P; Bergonzi P
    Riv Sper Freniatr Med Leg Alien Ment; 1965 Oct; 89(5):1225-50. PubMed ID: 5860488
    [No Abstract]   [Full Text] [Related]  

  • 10. A controlled comparison of oxypertine and perphenazine in schizophrenic psychoses.
    Svestka J; Náhunek K; Rodová A; Cesková E
    Act Nerv Super (Praha); 1974 Aug; 16(3):165-6. PubMed ID: 4608706
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rediscovery of a neuroleptic drug in a new form: clopenthixol].
    Meyers C; Lhoas JP; Huvelle R
    Schweiz Rundsch Med Prax; 1972 Jun; 61(26):869-71. PubMed ID: 4564517
    [No Abstract]   [Full Text] [Related]  

  • 12. Metiapine in acute schizophrenic patients.
    Kramer M; Blackwell B; Roth T; Wray M
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):465-9. PubMed ID: 4198308
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of flupenthixol (emergil)].
    Bourgeois M
    Ann Med Psychol (Paris); 1971 Mar; 1(3):434-43. PubMed ID: 5558678
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical studies with clopenthixol (sordinol) on chronic psychiatric patients.
    Bartolucci G; Lehmann HE; Ban TA; Lee H
    Curr Ther Res Clin Exp; 1966 Dec; 8(12):581-4. PubMed ID: 4962727
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of sordinol in mental disordes of vascular origin].
    Romanova IS; Banshchikov VM; Rozhanets RV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(8):1223-8. PubMed ID: 5700590
    [No Abstract]   [Full Text] [Related]  

  • 16. [Flupentixol (Fluanxol) in the treatment of apathic syndromes of schizophrenic origin].
    Strzyzewski W; Drogowski M
    Psychiatr Pol; 1971; 5(2):207-10. PubMed ID: 5576939
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative clinical-psychiatric experiences with thiaxanthene-derivatives with special consideration of flupenthixol].
    Poeldinger W
    Arzneimittelforschung; 1967 Sep; 17(9):1133-5. PubMed ID: 5632287
    [No Abstract]   [Full Text] [Related]  

  • 18. Clopenthixol: a controlled trial in chronic hospitalized schizophrenic patients.
    Kordas SK; Kazamias NG; Georgas JG; Papadokostakis JG
    Br J Psychiatry; 1968 Jul; 114(512):833-6. PubMed ID: 4874163
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinicl experience with flupenthixol in the treatment of chronic schizophrenia.
    Molcan J; Kukucová H; Koníková M
    Act Nerv Super (Praha); 1971; 13(3):180-1. PubMed ID: 5113828
    [No Abstract]   [Full Text] [Related]  

  • 20. A one-year trial of clopenthixol in chronic schizophrenia.
    Simpson GM; Arengo AD; Angus JW; Beckles ED; Rochlin D
    Can Psychiatr Assoc J; 1972 Aug; 17(4):321-4. PubMed ID: 4565509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.